BNET Industries
Last Fiscal Year Sales:$300.0M
- Private
- US
Dow Jones Description
Morton Grove Pharmaceuticals, Inc., located in Morton Grove, Illinois, is a specialty pharmaceutical company that develops, manufactures and markets prescription oral liquid and topical liquid pharmaceuticals. The company manufactures and markets over 50 products. Morton Grove Pharmaceuticals is today a leading manufacturer and marketer of prescription oral liquid pharmaceuticals in the United States. All of the company's core products are manufactured in Morton Grove Pharmaceuticals' 125,000 square foot, state-of-the-art facility. The company owns, manufactures and markets 52 prescription ANDA drugs, 33 prescription non-ANDA drugs and 3 OTC ANDA products. Currently, there are 11 ANDAs under active review. Morton Grove Pharmaceuticals distributes its products through Wholesalers, Chain Drug Stores and other Distributors throughout the United States. The company has a sales force of four National Accounts Directors in the field and three inside sales representatives. In total, Morton Grove has a work force of 300 employees.
CFO & Vice President
Rick LopatinNumber of Employees 270
Contact Information
6451 W Main St
Morton Grove, Illinois 60053-2633
(847) 967-5600
Peer Companies
NAICS Code Soap and Other Detergent Manufacturing: 325611
News & Analysis
Filter by
morton grove pharmaceuticals inc. - All News and Analysis
Morton Grove Pharmaceuticals
Morton Grove, IL DDMAC reviewed promotional pieces for Lindane Shampoo, USP,1% Lindane Shampoo issued by Morton Grove and by Alliant Pharmaceuticals Alliant. These pieces include websites promoting Lindane Shampoo and a promotional piece entitled "The Nit Picking News." The agency found that the websites and newsletter are misleading...
Morton Grove Pharmaceuticals Inc
CHICAGO -- Morton Grove Pharmaceuticals Inc. MGP is a Chicago-based specialty manufacturer of generic liquid pharmaceuticals and over-the-counter drug products. "Our specialty and focus is in liquids and such related products as nasal delivery," explains Richard O'Hara, director of sales and the field sales group. "We manufacture pharmaceuticals across...
Morton Grove Pharmaceuticals Inc
Morton Grove Pharmaceuticals Inc. 6451 West Main St. Morton Grove, Ill. 60053 Phone: (847) 967-5600 Fax: (847) 967-2211 Website: mgp-online.com Key contact: Frank Stiefel vice president of sales and marketing MORTON GROVE, Ill. -- Morton Grove Pharmaceuticals Inc. has been a leading supplier...
Morton Grove Pharmaceuticals
Morton Grove Pharmaceuticals, Morton Grove, IL, Jan. 14 Chicago. FDA cited Morton Grove for lack of a "documented action plan, conclusion or corrective action" in instances of stability failures in two lots of topical Clindamycin phosphate and one of topical Tretinoin solution. The stability failure investigation for Myphetene...
Morton Grove Pharmaceuticals
Morton Grove Pharmaceuticals, Morton Grove, IL, May 25 Chicago. Non-compliance with GMPs included commercial release of nystatin oral suspension USP, despite an out-of-specification OOS aerobic count; inadequate procedures to prevent microbiological contamination; inadequate cleaning procedures, leading to the contamination of Diphen AF with promethazine HCl and hyoscyamine oral drops with...
No small plans: upstart eyes drug firm goliaths. (Morton Grove Pharmaceuticals Inc.)(Company Profile)
Brian Tambi and his small drug company, Morton Grove Pharmaceuticals Inc., won't be threatening behemoths like Eli Lilly & Co. or Abbott Laboratories anytime soon. But in five years, he expects the company to be a heavy hitter. Mr. Tambi's entree to the big leagues: a...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Rick Lopatin | CFO & Vice President |
| Ned Jannotta | |
| Arda M. Minocherhomjee | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Edgar D. Jannotta | Board Director |
| Organization | Position | Status |
|---|---|---|
| Morton Grove Pharmaceuticals, Inc. | CFO & Vice President | Current |
| Baxter International Inc. | Former | |
| Grant Thornton LLP | Former | |
| University of Illinois | Bs In Accountancy | Former |
Ned Jannotta began his career as an associate with GTCR in 1985. After spending three years with GTCR, he left to join William Blair Capital Partners, where he was a managing director for over nine years. He rejoined GTCR in 1998 and became managing principal in 2002. Mr. Jannotta holds an AB in Politics, cum laude, from Princeton University and an MBA from Harvard University. Mr. Jannotta is a director of Chester Valley Pharmaceuticals, ForeFront Education, GeneraMedix Pharmaceuticals, Morton Grove Pharmaceuticals, Ovation Pharmaceuticals, and Trans Healthcare. In addition, Mr. Jannotta was a director and played a key role in GTCR's highly successful past investments in CuraScript and LifeCare Management Services.
| Organization | Position | Status |
|---|---|---|
| Morton Grove Pharmaceuticals, Inc. | Current | |
| Ovation Pharmaceuticals, Inc. | Current | |
| William Blair Capital Partners | Managing Director | Former |
| Harvard University | Mba | Former |
| Princeton University | Ab | Former |
| Organization | Position | Status |
|---|---|---|
| Chicago Growth Partners | Founding Partner | Current |
| Oakwood Medical Investors | Current | |
| Genoptix, Inc. | Current | |
| Morton Grove Pharmaceuticals, Inc. | Director | Current |
| NuVasive, Inc. | Director | Current |
| Cypress Medical Products Ltd. | Director | Current |
| Inhibitex, Inc. | Director | Current |
| Favrille, Inc. | Board of Directors | Current |
| Cubic Wafer, Inc | Board of Directors | Current |
| William Blair Capital Partners | Managing Member | Current |
| William Blair & Company, L.L.C. | Managing Member | Current |
| William Blair & Company LLC | Senior Health Care Analyst | Former |
| William Blair Capital Partners | managing member | Former |
| University of Washington School of Medicine | post-doctoral fellow in Pharmacology | Former |
| Point Biomedical Corporation | Board of Directors | Former |
| University of British Columbia | Ph.D | Former |
| University of Toronto | MS | Former |
| University of British Columbia | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| GTCR Golder Rauner, LLC | Senior Advisor | Current |
| William Blair Capital Partners | Chairman | Current |
| William Blair International, Limited | Chairman | Current |
| ComEd | Board of Directors | Current |
| Aon Corporation | Board of Directors | Current |
| Molex Incorporated | Director | Current |
| Sloan Valve Company | Director | Current |
| Morton Grove Pharmaceuticals, Inc. | Board Director | Current |
| Ovation Pharmaceuticals, Inc. | Board Director | Current |
| Commercial Club of Chicago | President | Former |
| Economic Club of Chicago | President | Former |
| William Blair Capital Partners | managing director | Former |
| GTCR Golder Rauner, LLC | Managing Principal | Former |
| LifeCare Management Services LLC | Director | Former |
| LifeCare Management Services LLC | Investor | Former |
| Harvard University | MBA | Former |
| Princeton University | AB | Former |
Executive News
-
Fail, Part Three: The Insiders
Industry Transcripts by Seeking Alpha
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
-
Donaldson Company Inc. F1Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 19, 2009about DCI



